- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 333/10 - Thiophène
Détention brevets de la classe C07D 333/10
Brevets de cette classe: 179
Historique des publications depuis 10 ans
|
14
|
16
|
12
|
9
|
12
|
5
|
10
|
7
|
8
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Allergan, Inc. | 2438 |
7 |
| Avoscience, LLC | 12 |
5 |
| Autophagysciences, Inc | 6 |
5 |
| Korea Institute of Science and Technology | 2075 |
4 |
| Texas Heart Institute | 111 |
4 |
| Bristol-myers Squibb Company | 4863 |
3 |
| The Regents of the University of California | 19517 |
3 |
| Sumitomo Chemical Company, Limited | 8988 |
3 |
| The Johns Hopkins University | 5533 |
3 |
| Richter Life Science Development AB | 9 |
3 |
| Daegu-gyeongbuk Medical Innovation Foundation | 102 |
3 |
| Geneora Pharma (Shijiazhuang) Co., Ltd. | 16 |
3 |
| F. Hoffmann-La Roche AG | 7942 |
2 |
| Agency for Science, Technology and Research | 3561 |
2 |
| Board of Regents of The Nevada System of Higher Education, on Behalf of The University of Nevada, Reno | 130 |
2 |
| CHDI Foundation, Inc. | 108 |
2 |
| Chinese PLA General Hospital | 38 |
2 |
| Givaudan SA | 1820 |
2 |
| Insmed Incorporated | 224 |
2 |
| Melinta Therapeutics, Inc. | 57 |
2 |
| Autres propriétaires | 117 |